TNFRSF11B and prostate carcinoma: In GSE16560, OPGhighTP53low patients showed poor prognosis while OPGlowTP53high patients showed better overall survival, indicating a potential relationship between p53 and OPG in determination of the progression of prostate cancer (Fig. 1i, j).